Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) EV-to-FCF : -0.85 (As of Jun. 22, 2024)

Cotinga Pharmaceuticals EV-to-FCF Chart

Cotinga Pharmaceuticals Annual Data
	Trend	Apr10	Apr11	Apr12	Apr13	Apr14	Apr15	Apr16	Apr17	Apr18	Apr19
EV-to-FCF		Get a 7-Day Free Trial					-8.48	-17.11	-12.14	-1.77	-1.19

Cotinga Pharmaceuticals Quarterly Data
	Apr15	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20
EV-to-FCF	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Cotinga Pharmaceuticals's EV-to-FCF

For the Biotechnology subindustry, Cotinga Pharmaceuticals's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cotinga Pharmaceuticals's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cotinga Pharmaceuticals's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Cotinga Pharmaceuticals's EV-to-FCF falls into.

Cotinga Pharmaceuticals EV-to-FCF Calculation

Cotinga Pharmaceuticals's EV-to-FCF for today is calculated as:

Cotinga Pharmaceuticals's current Enterprise Value is $0.33 Mil.
Cotinga Pharmaceuticals's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cotinga Pharmaceuticals  (OTCPK:COTQF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Cotinga Pharmaceuticals's PE Ratio for today is calculated as:

Cotinga Pharmaceuticals's share price for today is $0.0001.
Cotinga Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.075.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Cotinga Pharmaceuticals EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Cotinga Pharmaceuticals's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Business Description